Literature DB >> 7864077

Leukoregulin is a potent inducer of hyaluronan synthesis in cultured human orbital fibroblasts.

T J Smith1, H S Wang, C H Evans.   

Abstract

Leukoregulin, a 50-kDa glycoprotein lymphokine, can regulate the extracellular matrix in dermal fibroblasts. Here we investigate the effects of leukoregulin on the synthesis of glycosaminoglycans in human orbital fibroblasts. We demonstrate that leukoregulin enhances the incorporation of [3H]glucosamine into glycosaminoglycans. The effect is dose dependent in the concentration range tested (0.1-2 U/ml), is maximal at 1 U/ml, and is time dependent. [3H]glycosaminoglycan accumulation is enhanced 7.67 +/- 1.23-fold (SE, n = 7) in orbital fibroblast strains. Pulse-chase studies indicate that this enhanced accumulation is not a result of a decreased rate of macromolecular degradation. Radiolabeled material induced by leukoregulin is sensitive to Streptomyces hyaluronidase digestion. Dexamethasone (10(-8) M) and cycloheximide (10 micrograms/ml) can block the cytokine's stimulation of hyaluronan synthesis. [35S]sulfate incorporation into glycosaminoglycan is unaffected by leukoregulin. In dermal fibroblasts, leukoregulin increased hyaluronan synthesis 3.66 +/- 0.37-fold (n = 5 strains, P < 0.02 compared with orbit). The increase in hyaluronan synthesis in orbital fibroblasts is substantially greater than that observed previously with other cytokines, making leukoregulin a candidate molecular trigger in Graves' ophthalmopathy.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7864077     DOI: 10.1152/ajpcell.1995.268.2.C382

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  24 in total

Review 1.  Novel aspects of orbital fibroblast pathology.

Authors:  T J Smith
Journal:  J Endocrinol Invest       Date:  2004-03       Impact factor: 4.256

Review 2.  Potential role for bone marrow-derived fibrocytes in the orbital fibroblast heterogeneity associated with thyroid-associated ophthalmopathy.

Authors:  T J Smith
Journal:  Clin Exp Immunol       Date:  2010-08-19       Impact factor: 4.330

Review 3.  Cytokines, Graves' disease, and thyroid-associated ophthalmopathy.

Authors:  Andrew G Gianoukakis; Nicole Khadavi; Terry J Smith
Journal:  Thyroid       Date:  2008-09       Impact factor: 6.568

Review 4.  Insulin-like Growth Factor-I Receptor and Thyroid-Associated Ophthalmopathy.

Authors:  Terry J Smith; Joseph A M J L Janssen
Journal:  Endocr Rev       Date:  2019-02-01       Impact factor: 19.871

Review 5.  Pathogenesis of graves ophthalmopathy: implications for prediction, prevention, and treatment.

Authors:  James A Garrity; Rebecca S Bahn
Journal:  Am J Ophthalmol       Date:  2006-07       Impact factor: 5.258

6.  Leukoregulin induction of protein expression in human orbital fibroblasts: evidence for anatomical site-restricted cytokine-target cell interactions.

Authors:  D A Young; C H Evans; T J Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-21       Impact factor: 11.205

Review 7.  Graves' ophthalmopathy.

Authors:  Rebecca S Bahn
Journal:  N Engl J Med       Date:  2010-02-25       Impact factor: 91.245

Review 8.  TSH-receptor-expressing fibrocytes and thyroid-associated ophthalmopathy.

Authors:  Terry J Smith
Journal:  Nat Rev Endocrinol       Date:  2015-01-06       Impact factor: 43.330

Review 9.  The pathophysiology of thyroid eye disease: implications for immunotherapy.

Authors:  Raymond S Douglas; Shivani Gupta
Journal:  Curr Opin Ophthalmol       Date:  2011-09       Impact factor: 3.761

10.  Signal pathways regulating hyaluronan secretion into static and cycled synovial joints of rabbits.

Authors:  K R Ingram; A K T Wann; R M Wingate; P J Coleman; N McHale; J R Levick
Journal:  J Physiol       Date:  2009-07-21       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.